Radionuclide imaging of bone marrow disorders

63Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

Abstract

Noninvasive imaging techniques have been used in the past for visualization the functional activity of the bone marrow compartment. Imaging with radiolabelled compounds may allow different bone marrow disorders to be distinguished. These imaging techniques, almost all of which use radionuclide-labelled tracers, such as 99mTc-nanocolloid, 99mTc-sulphur colloid, 111In-chloride, and radiolabelled white blood cells, have been used in nuclear medicine for several decades. With these techniques three separate compartments can be recognized including the reticuloendothelial system, the erythroid compartment and the myeloid compartment. Recent developments in research and the clinical use of PET tracers have made possible the analysis of additional properties such as cellular metabolism and proliferative activity, using 18F-FDG and 18F-FLT. These tracers may lead to better quantification and targeting of different cell systems in the bone marrow. In this review the imaging of different bone marrow targets with radionuclides including PET tracers in various bone marrow diseases are discussed. © 2010 The Author(s).

Cite

CITATION STYLE

APA

Agool, A., Glaudemans, A. W. J. M., Boersma, H. H., Dierckx, R. A. J. O., Vellenga, E., & Slart, R. H. J. A. (2011, January). Radionuclide imaging of bone marrow disorders. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-010-1531-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free